EU fines pharmaceutical companies Teva and Cephalon €60m over alleged pay-for-delay deal

"Teva’s and Cephalon’s pay-for-delay agreement harmed patients and national health systems, depriving them of more affordable medicines," said EU competition commissioner, Margrethe Vestager.